Location: Home
  • search
  • go
  • Relate News
  • 10/13/2020CDE Issues the Technical Guidelines for Clinical Evaluation of Radioac...
  • 10/13/2020CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 10/13/2020SAMR Solicits Comments on the Draft Guide to Antimonopoly in the Bulk ...
  • 10/13/2020CRO PPD Opens New Clinical Research Lab in Suzhou
  • 10/13/2020China Reviews Proposed Drug Patent Link Related Amendment to the Paten...
  • 10/12/2020CDE Issues the Clinical Requirements for Drugs Marketed Outside China ...
  • 10/12/2020Antengene Establishes New Drug Discovery Center in Shanghai
  • 10/12/2020HitGen to Acquire Vernalis for $25M in Cash
  • 10/12/2020China Sharpens Focus on Healthcare Cost Containment amid a Basket of M...
  • 10/11/2020CStone Announces Completion of $200 million Share Sale to Pfizer
  • 10/11/2020Antengene Announces Collaboration with WuXi Biologics to Advance the D...
  • 10/11/20202020 Fall/Winter Promotion - Pharma China publications
  • 10/10/2020Innovent and Lilly Announce the NMPA Approval of HALPRYZA® (Rituximab...
  • 10/10/2020CDE Seeks Comments on Draft ICH Guideline E14-S7B
  • 10/10/2020NHSA and MOF Issues Joint Notice to Advance the Trial for Inter-Provin...
  • 10/9/2020Everest Medicines Launches IPO in Hong Kong
  • 10/9/2020Corvus Pharma to Enter China through JV with Local Investor Group
  • 10/9/2020Fosun's Hengenix to Initiate Trial of COVID-19 Antibody Drug in the U....
  • 10/9/2020China Reduces VAT on A New Batch of Anticancer Drugs
  • 10/9/2020Recent Executive Moves
  • 10/9/2020NMPA Issues the Guide to Pharmaceutical Contract Manufacture Quality A...
  • 10/9/2020WiCON Publishes the China Pharmaceutical Guide 2020 (15th Edition)
  • 10/8/2020Boehringer Ingelheim Pledges Continued Direct Investments in China
  • 10/8/2020Genor Completes $371 Million Hong Kong IPO; Market Cap Reaches $1.8B
  • 10/8/2020Lilly and Innovent Close the Expanded Global Collaboration on TYVYT (S...
  • 10/8/2020WiCON|Pharma China Is Now on Twitter, Facebook and LinkedIn
  • 10/8/2020Simultaneous Development of Zanubrutinib in the U.S. and China Demonst...
  • 10/7/2020OBI Pharma Taps Delos to Develop Its Drugs in China
  • 10/7/2020BioShin Raises $60M in Series A Funding to Advance Neuroscience Pipeli...
  • 10/7/2020Harbour BioMed Announces Two NMPA IND Clearances for Phase 1 & Combo ...
  • Page:218/775 Total number of articles:23249: [First][<<] [216] [217] [218] [219] [220] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group